The last IMIBIC-P2Med fellow joined the programme in May 2022. Silvia has enjoyed before an MSCA-Individual Fellowship in the same group since her return to IMIBIC in 2019. Most of the fellows are finishing their second year (Maribel, Marina, Almudena…
New Review Article
Vaccination is widely considered one of the greatest achievements of modern medicine. Vaccines save millions of lives and protect millions more from getting sick. However, each year roughly three million individuals still die of vaccine-preventable diseases, including respiratory infections, tuberculosis,…
Our first paper is out!
A recently published Open Access article represents the first demonstration that the plasma levels of miR-107 might represent a useful personalized diagnostic biomarker of prostate cancer since its levels are increased in plasma from prostate cancer patients compared with control…